MedElevator Войти в исследования
← Поиск публикаций

DOI 10.31557/apjcp.2025.26.12.4549

Медицинская библиотека · Asian Pacific journal of cancer prevention : APJCP · 2025

Innovations in Oncology Diagnostics: Genetic Research and Liquid Biopsy as Tools of Personalised Medicine.

Niyazbekova Lazzat, Marku Ervin, Petkov Plamen, Karimova Nazgul, Ulmasov Firdavs

СтатьяОбзорПеревод пока не подготовлен

Аннотация

OBJECTIVE

The aim of this study was to analyze contemporary approaches to cancer diagnosis and treatment using liquid biopsy, with a particular focus on the efficacy of oncogenic biomarker detection in various biological fluids.

MATERIALS AND

METHODS

This study examined scientific literature from the last five years on the use of liquid biopsy in oncology, focusing on tumour marker detection in blood, plasma, saliva, and urine, along with their analytical significance and clinical implications.

RESULTS

Tumour-derived circulating nucleic acids, circulating tumour cells, and secretory vesicles isolated from biological fluids were shown to be highly informative. These enabled the detection of mutations in key oncogenic markers (AR, KRAS, EGFR, PIK3CA, PTEN, P53), quantification of regulatory RNAs (BCAR4, UCA1, H19, miR-21, miR-146a-5p, miR-181a), and assessment of translational levels of proteins such as Cfh, Muc1, Bst2, Er, and Ccne1. Transcriptomic analysis provided insights into T-lymphocyte activity, tumour resistance to gefitinib and tyrosine kinase inhibitors, and the suppression of tumour progression. The expression of proteoglycans isolated from exosomes was identified as a marker of early-stage pancreatic cancer. The titre of CTCs enabled the prediction of recurrence in 64% of patients with lung carcinoma and 100% of post-surgical cases of colorectal cancer, facilitating hormone therapy adjustments in prostate cancer patients. Mutations in the EGFR gene, amplified from persistent deoxyribonucleic acid, were used to adjust chemotherapy regimens throughout the course of treatment.

CONCLUSION

The analysis of material obtained from the biological fluids of oncology patients enabled disease prognosis, risk assessment of progression, and the determination of optimal approaches to personalised therapy, ultimately improving treatment efficacy. The collected data may serve as a foundation for clinically valuable laboratory studies and practical research.

Для цитирования: Niyazbekova Lazzat, Marku Ervin, Petkov Plamen, Karimova Nazgul, Ulmasov Firdavs. Innovations in Oncology Diagnostics: Genetic Research and Liquid Biopsy as Tools of Personalised Medicine.. Asian Pacific journal of cancer prevention : APJCP. 2025. DOI: 10.31557/apjcp.2025.26.12.4549.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.